TARID and TCF21 are silent and heavily covered by DNA methylation in non-small cell lung cancer (NSCLC), head and neck squamous cell carcinomas (HNSCC) and ovarian cancers (OVC) [49]. Here, TARID is linked to head and neck squamous cell carcinoma.